Is Lipoplatinum Monotherapy an Active Alternative in Second Line Treatment of Metastatic Non–Small Cell Lung Cancer? A Phase II Trial

Autor:	Britt Rudnas, Emiliano Tamburini, Alberto Ravaioli, Manuela Imola, Fabrizio Drudi, Manuela Fantini, Stefania Nicoletti, Maximilian Papi, Cinzia Possenti, Wainer Zoli, Maurizio Marangolo, Ilaria Panzini, E. Pasquini, Lorenzo Gianni
Rok vydání:	2009
Předmět:	Cisplatin Oncology Liposome medicine.medical_specialty Second line treatment business.industry Lipoplatin medicine.disease respiratory tract diseases Internal medicine medicine Non small cell Lung cancer business Toxicity profile medicine.drug
Zdroj:	Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy ISBN: 9781603274586
DOI:	10.1007/978-1-60327-459-3_29
Popis:	Lipoplatin is a liposome encapsulated form of cisplatin. Phase I studies on Lipoplatin showed an excellent toxicity profile of the compound. Therefore we performed a phase II trial in heavily pre-treated patients with advanced non–small cell lung cancer (NSCLC).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6b8af1f6bba1c019647a51efbf07c3ff https://doi.org/10.1007/978-1-60327-459-3_29 Zobrazit plný text záznamu